Purchase Order 75N95024P00661
Award Date
9/23/24
Potential Completion Date
9/22/25
Potential Value
$98K
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
QPS LLC
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newark, DE, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
7
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $129,586.25 firm fixed-price purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Melior Discovery Inc. to provide continuous rodent and non-rodent pharmacokinetic assessment services. The contract was awarded under the NINDS Division Translational Research - Continuous Rodent and Non-Rodent Pharmacokinetic (PK) Assessments solicitation, which sought commercial sources with the capability to conduct routine rodent...
This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to Pharmaron, Inc. The $101,372.00 firm fixed-price delivery order contract is part of the NIH Bioanalysis Testing Services 2015-2020 indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. Under this award, Pharmaron will provide a range of preclinical research services to support NIDA's drug discovery and development initiatives,...
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to Pharmaron, Inc. The $143,550.00 firm fixed-price delivery order falls under the NIH Bioanalysis Testing Services 2015-2020 contract vehicle, which provides preclinical research services to support drug discovery and development. The contract does not have a set-aside designation. Pharmaron, a minority-owned, for-profit organization...
<p>This is a $10,000.00 firm fixed price purchase order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian federal agency, to Lin Jiunn. The contract is for Drug Metabolism and Pharmacokinetics (DMPK) services in support of the Blueprint Neurotherapeutics Network (BPN), HEAL, and Biologics programs. The period of performance is from July 8, 2025 to July 7, 2026. The contract was not set aside for any socioeconomic category.</p>
This federal contract award is to Pharmaron, Inc., a global contract research organization (CRO) that provides preclinical research services for pharmaceutical and biotechnology companies, as well as government agencies. The contract, valued at $24,900, is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH). The award does not have a set-aside designation. Pharmaron, which is classified as a...
This is a $4,130 firm-fixed-price purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, to Pharmaron (Exton) Lab Services LLC, doing business as Absorption Systems. The contract is for an in-vivo pharmacokinetic (PK) study to determine the optimal formulation for dosing cytochrome P inhibitors and analyzing their concentrations in mouse plasma. This contract is not designated as a small business set-aside. Pharmaron is a global...
This firm fixed-price purchase order contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart, Lung, and Blood Institute to Pharmaron, Inc., a minority-owned for-profit contract research organization, to conduct Good Laboratory Practice (GLP) toxicity studies in rats and dogs. The $102,250.00 contract supports the Institute's Investigational New Drug (IND) enablement project, with Pharmaron performing services such as...
This is a federal purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The contract, valued at $22,818.36, requires Qiagen to provide samples of human blood, rodent blood, and rodent brain expression for analysis by the researcher Leandro Vendruscolo. The contract is a firm fixed price purchase order with a...
This is a $199,812 firm fixed price purchase order awarded by the National Institutes of Health's (NIH) National Institute on Aging (NIA) to QPS Austria GMBH, a contract research organization. The contract is for in vivo efficacy studies of a candidate Alzheimer's treatment in a transgenic mouse model. This award is part of the NIA's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study, which aims to identify FDA-approved drugs that may be repurposed as disease-modifying...
This is a task order award under the Pharmacology and Toxicology for Therapeutics Program (PTTP) indefinite delivery, indefinite quantity (IDIQ) contract with the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The $2,909,141.00 task order is for "Continuous Rodent and Non-Rodent Pharmacokinetic Assessments" and has a completion date of May 19, 2022. The prime contractor is Sri International, a non-profit research institute that provides a...